Greenwich LifeSciences In...

NASDAQ: GLSI · Real-Time Price · USD
12.11
0.03 (0.25%)
At close: Aug 15, 2025, 3:59 PM
12.17
0.50%
After-hours: Aug 15, 2025, 07:26 PM EDT

Greenwich LifeSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.61K 3.61K 5.42K 5.42K 5.42K 5.42K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1.81K 2.71K 1.81K 2.71K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 2.71K 1.81K 903.00
Gross Profit
903.00 n/a 2.71K 1.81K 1.81K 1.81K -3.61K -3.61K -3.61K -3.61K -3.61K -3.61K -3.61K -3.61K -2.71K -1.81K -903
Operating Income
-16.76M -16.01M -10.76M -10.54M -9.62M -9.33M -9.39M -9.27M -8.29M -8.04M -7.52M -6.01M -5.99M -4.6M -3.37M -2.76M -2.22M
Interest Income
182.97K 223.01K 268.36K 319.16K 383.89K 436.06K 450.94K 403.84K 311.62K 215.02K 127.35K 66.88K 43.34K 27.37K 10.87K 7.3K 3.6K
Pretax Income
-16.57M -15.79M -10.5M -10.22M -9.24M -8.89M -8.94M -8.86M -7.98M -7.83M -7.4M -5.94M -5.94M -4.57M -3.36M -2.75M -2.22M
Net Income
-16.57M -15.79M -10.5M -10.22M -9.24M -8.78M -8.67M -8.53M -7.62M -7.56M -7.28M -5.89M -5.92M -4.57M -3.36M -2.75M -2.22M
Selling & General & Admin
3.4M 3.06M 1.63M 1.54M 1.56M 1.63M 1.56M 1.88M 1.65M 1.56M 1.44M 991.33K 1.05M 1.04M 1.28M 1.17M 1.03M
Research & Development
13.36M 12.95M 9.13M 8.99M 8.07M 7.7M 7.82M 7.39M 6.64M 6.48M 6.08M 5.02M 4.94M 3.56M 2.09M 1.6M 1.19M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.00 0.00 0.00
Operating Expenses
16.76M 16.01M 10.76M 10.54M 9.62M 9.33M 9.39M 9.27M 8.29M 8.04M 7.52M 6.01M 5.99M 4.6M 3.37M 2.76M 2.22M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
903.00 n/a -1.81K -1.81K -1.81K -904 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
16.76M 16.01M 10.76M 10.54M 9.62M 9.33M 9.39M 9.27M 8.29M 8.04M 7.52M 6.01M 5.99M 4.6M 3.37M 2.76M 2.22M
Income Tax Expense
n/a n/a -3 -3 -3 -116.18K -267.16K -331.2K -358.43K -242.25K -91.27K -27.23K n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
13.17M 13.15M 13.14M 12.91M 12.86M 12.85M 12.85M 12.85M 12.85M 12.65M 12.82M 12.92M 13.06M 12.9M 12.97M 12.9M 12.8M
Shares Outstanding (Diluted)
13.17M 13.15M 13.14M 12.91M 12.86M 12.85M 12.85M 12.85M 12.85M 12.65M 12.82M 12.92M 13.06M 12.9M 12.97M 12.9M 12.8M
EPS (Basic)
-1.27 -1.21 -0.8 -0.79 -0.72 -0.69 -0.69 -0.68 -0.61 -0.6 -0.57 -0.45 -0.45 -0.35 -0.3 -0.26 -0.22
EPS (Diluted)
-1.27 -1.21 -0.8 -0.79 -0.72 -0.69 -0.69 -0.68 -0.61 -0.6 -0.57 -0.45 -0.45 -0.35 -0.3 -0.26 -0.22
EBITDA
-16.71M -15.96M -10.76M -10.53M -9.62M -9.32M -9.38M -9.26M -8.29M -8.04M -7.52M -6M -5.98M -4.59M -3.37M -2.76M -2.22M
EBIT
-16.71M -15.97M -10.76M -10.54M -9.62M -9.33M -9.39M -9.27M -8.29M -8.04M -7.52M -6.01M -5.99M -4.6M -3.37M -2.76M -2.22M
Depreciation & Amortization
3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K 3.61K